Three-dimensional maximum a posteriori (MAP) imaging with radiopharmaceuticals labeled with three Cu radionuclides
To access this article, please choose from the options below
PII: S0969-8051(05)00276-3
doi:10.1016/j.nucmedbio.2005.11.001
© 2006 Elsevier Inc. All rights reserved.
